Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
GT Biopharma (OXIA.F) Q4 2024 Earnings
OXIA.F
14
Nov
Confirmed
Q2 2024
Q3 2024
Q4 2024
-2.56
-2.19
-1.82
-1.45
Details
Expected EPS
-2.564082
Actual EPS
-1.4529798
Surprise EPS
1.11
Surprise Percent
+43.33%
Description
GT Biopharma (OXIA.F) has reported earnings of -1.4529798 per share for Q4 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login